Is the Evaluation of Anal Distensibility by Endoflip® Technique Useful for the Diagnosis of Anismus?
NCT ID: NCT04155307
Last Updated: 2025-09-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
61 participants
INTERVENTIONAL
2020-01-14
2024-05-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Anismus is one of the main causes of terminal constipation. Anismus diagnosis is retained if 2 out of 3 examinations (manometry, electromyogram, defecography) are positive.
EndoFLIP® is a new medical device developed to measure distensibility of a hollow organ. Anal EndoFLIP® l could be a more sensitive and specific tool for detecting anismus in patients with distal constipation.
60 patients suffering from distal constipation will be included in order to perform, in addition to the usual examinations, an anal EndoFlip in order to test the sensitivity and specificity of this method for the diagnosis of anismus.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Normal Values in Ano-rectal 3D High Resolution Manometry
NCT01710579
Anorectal Manometery in Pediatric Chronic Refractory Constipation
NCT06543979
External Anal Sphincter Fatigability
NCT04067453
Anal Canal Functional Assessment Using EndoFLIP
NCT04741893
Does Body Position Influence Pressure Recording by High-resolution Manometry ?
NCT01946334
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Detection of anismus in patients with distal constipation
Anal EndoFLIP®
Anal EndoFLIP® measure to evaluate anal compliance
Anal Manometry
Anal Manometry done in standard care
Defecography
Defecographydone in standard care
Electromyogram
Electromyogram done in standard care
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Anal EndoFLIP®
Anal EndoFLIP® measure to evaluate anal compliance
Anal Manometry
Anal Manometry done in standard care
Defecography
Defecographydone in standard care
Electromyogram
Electromyogram done in standard care
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patient with distal constipation defined according to the Rome IV criteria, for at least 3 months and verified by a transit time study showing a predominant slowing of markers at the recto-sigmoid level.
* patient who read and signed the informed consent form
Exclusion Criteria
* Pregnant woman or woman with no effective contraception and of childbearing age
* Patient with inflammatory bowel disease, ischemic colitis, history of colon or rectal cancer, infectious colitis or proctologic disease.
* Patient with anorectal malformation
* Patient with an history of pelvic floor radiotherapy
* Patient with a digestive stoma
* Insertion of the probe impossible or painful
* Patient who has participated to a clinical trial within 30 days prior to the inclusion visit
* Patient not understanding or reading French
* Patients under guardianship, curatorship, safeguard of justice
* Patient without liberty by administrative or judicial decision
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Rouen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Laura BRIL, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Rouen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rouen University Hospital
Rouen, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018/0347/HP
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.